Expected Rebound in Elective and Medically Necessary Procedures

Expected Rebound in Elective and Medically Necessary Procedures

Rafi Musher • May 26, 2020
Rafi Musher • May 26, 2020

Share

Stax's short term outlook (1-6 month) across the healthcare sector.

Many healthcare companies have similar questions about return to patient volumes, which locations will see a return to procedures, and the long-term prognosis for healthcare. To facilitate the process and speed up the effort, Stax has initiated new field research on expectations for return to procedures and developed a fast framework to help management teams, boards of directors, and investors determine the short, medium, and long- term implications for healthcare and their particular organizations.


The process is informed by 20 years of providing healthcare leaders with insights for strategic operating and investment decisions. It is inclusive, iterative, data-rich, and can be done remotely.


With a 20+ year record of successfully modeling healthcare volumes, supply and demand, and competitive market dynamics across the spectrum of providers, we know how public and private spend can be modeled to help forecast overall patient volumes nationally and locally. We have a range of traditional and creative datasets at our fingertips and understand how to conduct large-scale primary research with consumers, healthcare professionals, and providers. Healthcare choices are complex, and there is a tremendous amount of data to bring together and model to provide strong parameters on patient volumes and market share potential, for management teams and investors for the short and long term.




Contact Us

Read More

Featured by Carta: PE is trying to figure out where AI fits into the future of healthcare
By Rob Larson September 8, 2026
Rob Larson met with Carta to discuss the growing problem of supply and demand in the US healthcare system, and how a technological revamp could be necessary. Read the full feature here.
From AI Discovery to Advertising: Where Investors Should Look Next
By Palash Misra August 14, 2026
Palash Misra explores how AI is changing the marketing landscape, with portfolio companies potentially rethinking how they reach and convert customers. Read more here.
Featured by Carta: After the “SaaS-pocalypse,” a new era begins for PE-backed software companies
By Palash Misra August 14, 2026
Palash Misra met with Carta to discuss the role of AI in SaaS investment and how investors are reprioritizing what they value in a business. Read the feature here.
Grant Thornton Stax Supports MainSail Partners in the Strategic Combination of MirrorWeb and Red Oak
August 7, 2026
Grant Thornton Stax is proud to have supported MainSail Partners in the strategic combination of MirrorWeb and Red Oak. Click to read more. ​
MSMs: Separating Durable Platforms from Disruptable Networks
By Tyler Veit & Kate Philbrick July 22, 2026
Multi-stakeholder models sit at an attractive intersection of fragmented markets and PE investors are looking to capitalize. Click here to read our latest insights on MSMs.
Grant Thornton Stax Provides Sell-side Support to Inspectorio on Investment by Apax
July 16, 2026
Grant Thornton Stax congratulates Inspectorio, a production-chain management platform, on its growth investment by Apax Digital Funds, the growth equity arm of Apax. Read more here.
Show More